| Name | Title | Contact Details |
|---|
Genetic Alliance is a Washington, DC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Our vision is to serve our communities’ evolving healthcare needs by cultivating a network of compassionate, dedicated professionals. We are committed to working together, using best practices, improving quality, and assuring an exceptional patient experience. Our highest priority is caring for people - the friends, family and neighbors whom we serve in our community. We are committed to providing an environment based on respect and one which encourages personal and profession growth.
Founded nearly 50 years ago and employing over 2,500 clinical, regulatory, and operational pharmacy professionals, Comprehensive Pharmacy Services is the nation`s oldest and largest provider of pharmacy support services to more than 700 hospitals and healthcare facilities across the United States and Puerto Rico. CPS helps hospital pharmacists tackle complex problems such as medication reconciliation, hyper-inflated drug costs, standardization, centralized distribution, regulatory & compliance, and 340B programs leading to increased quality, reduced admissions and lower costs. Services provided by CPS include pharmacy management, pharmacy consulting, specialized pharmacy services, telepharmacy, 340B program compliance assurance, ambulatory & retail pharmacy services, medication related transition of care, and pharmacy analytics.
Avancen is a Mount Pleasant, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Braxia Scientific is a medical research company with clinics that provide innovative ketamine treatments for persons with depression and related disorders. Through its medical solutions, Braxia aims to reduce the illness burden of brain-based disorders, such as major depressive disorder among others. Braxia is primarily focused on (i) owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and (ii) research activities related to discovering and commercializing novel drugs and delivery methods. Braxia seeks to develop ketamine and derivatives and other psychedelic products from its IP development platform. Through its wholly owned subsidiary, the Canadian Rapid Treatment Center of Excellence Inc., Braxia currently operates multidisciplinary community-based clinics offering rapid-acting treatments for depression located in Mississauga, Toronto, Kitchener-Waterloo, Ottawa, and Montreal.